UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Chest, ISSN 0012-3692, 07/2009, Volume 136, Issue 1, pp. 10 - 15
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Respiratory system : syndromes and miscellaneous diseases | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Hypertension, Pulmonary - mortality | Pulmonary Emphysema - physiopathology | Prevalence | Pulmonary Ventilation | Humans | Middle Aged | Risk Factors | Hypertension, Pulmonary - physiopathology | Male | Survival Rate | Pulmonary Artery | Case-Control Studies | Idiopathic Pulmonary Fibrosis - mortality | Female | Aged | Idiopathic Pulmonary Fibrosis - complications | Idiopathic Pulmonary Fibrosis - physiopathology | Pulmonary Emphysema - epidemiology | Pulmonary Emphysema - mortality | Cohort Studies | Hypertension, Pulmonary - complications | Smoking | Complications and side effects | Pulmonary fibrosis | Prognosis | Emphysema, Pulmonary | Development and progression | Comparative analysis | Pulmonary hypertension | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2001, Volume 164, Issue 6, pp. 1025 - 1032
Usual interstitial pneumonia | Prospective studies | Survival rate | Pulmonary fibrosis physiopathology | Smoking physiopathology | Idiopathic pulmonary fibrosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Multivariate Analysis | Prognosis | Prospective Studies | Age Factors | Lung Diseases, Interstitial - pathology | Humans | Middle Aged | Male | Lung Diseases, Interstitial - mortality | Time Factors | Smoking - physiopathology | Adult | Female | Pulmonary Gas Exchange | Lung Diseases, Interstitial - physiopathology | Pulmonary Fibrosis - mortality | Lung - pathology | Proportional Hazards Models | Pulmonary Fibrosis - pathology | Biopsy | Pulmonary Fibrosis - physiopathology | Sex Factors | Survival Analysis | Aged | Respiratory Function Tests | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 04/2014, Volume 189, Issue 7, pp. 825 - 831
Endpoints | Clinical trial | Hospitalization | Idiopathic pulmonary fibrosis | Mortality | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Recombinant Proteins - therapeutic use | Follow-Up Studies | Interferon-gamma - therapeutic use | Randomized Controlled Trials as Topic - methods | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Models, Statistical | Cause of Death | Clinical Trials, Phase III as Topic - methods | Feasibility Studies | Sample Size | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Pyridones - therapeutic use | Research Design | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2012, Volume 185, Issue 1, pp. 67 - 76
Biomarkers | Adhesion molecules | MMP-7 | Personalized medicine | Mortality prediction | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Cell Adhesion Molecules - blood | Enzyme-Linked Immunosorbent Assay - methods | Predictive Value of Tests | Matrix Metalloproteinase 7 - blood | Humans | Proportional Hazards Models | Male | Biomarkers - blood | Idiopathic Pulmonary Fibrosis - blood | S100A12 Protein | Vascular Cell Adhesion Molecule-1 - blood | Matrix Metalloproteinase 1 - blood | Idiopathic Pulmonary Fibrosis - mortality | S100 Proteins - blood | Survival Analysis | Female | Intercellular Adhesion Molecule-1 - blood | Aged | Interleukin-8 - blood | Matrix Metalloproteinases - blood | Cohort Studies | Index Medicus | Abridged Index Medicus | mortality prediction | adhesion molecules | biomarkers | personalized medicine
Journal Article
The European respiratory journal, ISSN 0903-1936, 09/2015, Volume 46, Issue 3, pp. 795 - 806
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Severity of Illness Index | Global Health | Humans | Middle Aged | Europe - epidemiology | Male | Cause of Death | Incidence | Idiopathic Pulmonary Fibrosis - epidemiology | South America - epidemiology | Idiopathic Pulmonary Fibrosis - diagnosis | Survival Analysis | Adult | Female | Aged | North America - epidemiology
Journal Article
Respiratory medicine, ISSN 0954-6111, 2016, Volume 113, pp. 74 - 79
Pulmonary/Respiratory | Acute exacerbations | Forced vital capacity | Mortality | Disease progression | Quality of life | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Drug Administration Schedule | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Male | Treatment Outcome | Diarrhea - chemically induced | Indoles - administration & dosage | Randomized Controlled Trials as Topic | Enzyme Inhibitors - administration & dosage | Vital Capacity - drug effects | Clinical Trials, Phase III as Topic | Female | Indoles - pharmacology | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Clinical Trials, Phase II as Topic | Pulmonary fibrosis | Lung diseases | Data collection | Diarrhea | Pharmaceutical industry | Drug dosages | Growth factors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1189 - 1191
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | United States | Humans | Enzyme Inhibitors - pharmacology | Drug Approval | Enzyme Inhibitors - therapeutic use | Cause of Death | Advisory Committees | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Vital Capacity - drug effects | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Indoles - pharmacology | Indoles - therapeutic use | Idiopathic Pulmonary Fibrosis - physiopathology | Pyridones - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridones - pharmacology | United States Food and Drug Administration | Studies | Pulmonary fibrosis | Mortality | Lung diseases | Fibrosis | FDA approval | Drug therapy | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 03/2006, Volume 129, Issue 3, pp. 746 - 752
PFT = pulmonary function test | pulmonary artery | pulmonary hypertension | catheterization | PA = pulmonary artery | CI = confidence interval | PAH = pulmonary arterial hypertension | exercise test | ILD = interstitial lung disease | LV = left ventricular | mPAP = mean pulmonary arterial pressure | 6MWT = 6-min walk test | pulmonary fibrosis | mortality | pulmonary function tests | Dlco = diffusing capacity of the lung for carbon monoxide | IPF = idiopathic pulmonary fibrosis | HR = hazard ratio | Spo2 = pulse oximetric saturation | PAWP = pulmonary artery wedge pressure | TLC = total lung capacity | Pulmonary fibrosis | Catheterization | Mortality | Pulmonary function tests | Exercise test | Pulmonary artery | Pulmonary hypertension | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Pulmonary Fibrosis - mortality | Spirometry | Hypertension, Pulmonary - diagnosis | Prevalence | Comorbidity | Pulmonary Fibrosis - complications | Humans | Middle Aged | Proportional Hazards Models | Male | Hypertension, Pulmonary - epidemiology | Pulmonary Fibrosis - epidemiology | Exercise Test | Sensitivity and Specificity | Survival Analysis | Female | Hypertension, Pulmonary - etiology | Causes of | Patient outcomes | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Thorax, ISSN 0040-6376, 06/2011, Volume 66, Issue 6, pp. 462 - 467
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Idiopathic Pulmonary Fibrosis - epidemiology | Age Distribution | Idiopathic Pulmonary Fibrosis - mortality | Primary Health Care - statistics & numerical data | Epidemiologic Methods | Humans | Middle Aged | Aged, 80 and over | Sex Distribution | Aged | Mortality - trends | United Kingdom - epidemiology | Development and progression | Pulmonary fibrosis | Diagnosis | Patient outcomes | Codes | Mortality | Lung diseases | Studies | Datasets | Databases | Medical prognosis | Population | Trends | Age | Cancer | Chronic illnesses | Index Medicus
Journal Article
Thorax, ISSN 0040-6376, 11/2006, Volume 61, Issue 11, pp. 980 - 985
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Pulmonary Fibrosis - mortality | Prevalence | Sarcoidosis, Pulmonary - mortality | Humans | Middle Aged | Male | Pulmonary Fibrosis - epidemiology | Incidence | Sarcoidosis, Pulmonary - epidemiology | Survival Analysis | Aged, 80 and over | Adult | Female | Poisson Distribution | Aged | United Kingdom - epidemiology | Cohort Studies | Pulmonary fibrosis | Demographic aspects | Sarcoidosis | Mortality | United Kingdom | Reports | Statistics | Disease | Medical prognosis | Population | Software | Workloads | Age | Family physicians | Index Medicus | Interstitial Lung Disease | epidemiology | sarcoidosis | idiopathic pulmonary fibrosis
Journal Article
The European respiratory journal, ISSN 0903-1936, 02/2017, Volume 49, Issue 2, pp. 1601592 - 1601592
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Multivariate Analysis | Age Distribution | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Lung - physiopathology | Australia - epidemiology | Vital Capacity | Idiopathic Pulmonary Fibrosis - mortality | Survival Analysis | Aged, 80 and over | Adult | Carbon Monoxide - blood | Female | Registries | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Respiratory function | Pulmonary fibrosis | Mortality | Lung diseases | Fibrosis | Population studies | Physiology | Carbon monoxide | Age
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9779, pp. 1760 - 1769
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Follow-Up Studies | Administration, Oral | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Dose-Response Relationship, Drug | Vital Capacity - drug effects | Disease-Free Survival | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Female | Aged | Pyridones - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridones - adverse effects | Usage | Care and treatment | Pulmonary fibrosis | Diagnosis | Research | Health aspects | Antifibrinolytic agents | Studies | Clinical trials | Lungs | Lung diseases | Regulatory approval | Index Medicus | Abridged Index Medicus | antiinflammatory agents | Respiratory function | Lung | Mortality | Anti-Inflammatory Agents, Non-Steroidal | Pyridones | Idiopathic Pulmonary Fibrosis | Life Sciences | Vital Capacity | Human health and pathology | Pulmonology and respiratory tract
Journal Article